Agribusiness Report Podcast: Andy LaVigne
AGRIBUSINESS REPORT PODCAST – Guest: Andy LaVigne is President and CEO of the American Seed Trade Association (ASTA) in Washington, DC. Today he talks about the importance of getting good … Read More
AGRIBUSINESS REPORT PODCAST – Guest: Andy LaVigne is President and CEO of the American Seed Trade Association (ASTA) in Washington, DC. Today he talks about the importance of getting good … Read More
The longest-running farm program in West Texas, the AgriBusiness Report is our daily interview program with decision-makers in the world of Agriculture. Today’s guest is American Seed Trade Association President & CEO Andy LaVigne.
The longest-running farm program in West Texas, the AgriBusiness Report is our daily interview program with decision-makers in the world of Agriculture. Today’s guest is American Seed Trade Association President & CEO Andy LaVigne.
The longest-running farm program in West Texas, the AgriBusiness Report is our daily interview program with decision-makers in the world of Agriculture. Today’s guest is Andy LaVigne, President & CEO of the American Seed Trade Association.
The longest-running farm program in West Texas, the AgriBusiness Report is our daily interview program with decision-makers in the world of Agriculture. Today’s guest is Andy LaVigne with the American Seed Trade Association
As the U.S. economy begins to thaw from a frigid year-long global shutdown due to COVID-19, one sign of optimism is pointing to another sign of frustration.
The longest-running farm program in West Texas, the AgriBusiness Report is our daily interview program with decision-makers in the world of Agriculture.
The longest-running farm program in West Texas, the AgriBusiness Report is our daily interview program with decision-makers in the world of Agriculture.
The longest-running farm program in West Texas, the AgriBusiness Report is our daily interview program with decision-makers in the world of Agriculture.
Agricultural groups are applauding an announcement by the EPA for a proposal to streamline the regulation of some biotech advancements.